Fri May 30 00:10:00 UTC 2025: **Kennedy’s COVID-19 Vaccine Policy Sparks Controversy, Limits Recommendations**
**Washington D.C.** – New COVID-19 vaccine recommendations issued by Health Secretary Robert F. Kennedy Jr. are generating significant controversy among medical professionals and organizations. Announced via social media, the policy drastically narrows the recommended recipients of the vaccine to those over 65 and individuals with pre-existing health conditions, bypassing the usual scientific review process.
This change raises concerns about access to vaccines for others, including healthcare workers, healthy adults under 65 with vulnerable family members, pregnant women, and children. Experts worry insurance coverage, which typically follows federal recommendations, may be impacted, potentially requiring out-of-pocket costs for those outside the newly designated groups.
Dr. Jesse Goodman, professor of medicine and infectious diseases at Georgetown University, expressed concern over the lack of data supporting the policy shift, emphasizing the importance of transparent decision-making and the role of advisory committees. The American Academy of Pediatrics (AAP) and the Infectious Disease Society of America (IDSA) have also voiced strong objections.
The IDSA urged insurers to continue covering the COVID-19 vaccine for all Americans, and called on Congress to ensure appropriate decision-making processes within the Department of Health and Human Services.
While federal tracking of COVID-19 has ceased, local data indicates ongoing infections, hospitalizations, and deaths across all age groups. Despite a low vaccine uptake among children, COVID-19 continues to cause significant hospitalizations. A recent study in JAMA Pediatrics shows that children who had been infected with COVID were more likely to experience trouble sleeping, fussiness, poor appetite, a stuffy nose and cough.
Experts emphasize the safety and effectiveness of the COVID-19 vaccine, particularly for vulnerable populations, and stress its importance in preventing severe outcomes and long COVID. The Society for Maternal-Fetal Medicine strongly reaffirms its recommendation that pregnant patients receive the COVID-19 vaccine, at any point during pregnancy.
Dr. Sean O’Leary, chair of the AAP Committee on Infectious Diseases, expressed concern about the potential impact on families who wish to vaccinate, as the policy change could limit access.
Sen. Bill Cassidy, a physician, had previously stated that Kennedy assured him he would adhere to expert guidance on vaccinations and maintain the existing advisory committee structure. Kennedy’s recent actions appear to contradict these commitments.
First Piper 